The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
CLINICAL (AND BEYOND) IN-USE STABILITY STUDIES – CHALLENGES, CONSIDERATIONS AND CASE STUDIES
A review of the regulatory requirements and guidance recommendations to support storage conditions of reconstituted and/or diluted drug products during IND development and for BLA approval will be presented. Microbial challenge study design and data analysis will be discussed. Case studies will be presented to illustrate how the microbial challenge data support the label instructions for storage conditions.